BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27707736)

  • 1. Strict in vivo specificity of the
    Smith EC; Luc S; Croney DM; Woodworth MB; Greig LC; Fujiwara Y; Nguyen M; Sher F; Macklis JD; Bauer DE; Orkin SH
    Blood; 2016 Nov; 128(19):2338-2342. PubMed ID: 27707736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.
    Bauer DE; Kamran SC; Lessard S; Xu J; Fujiwara Y; Lin C; Shao Z; Canver MC; Smith EC; Pinello L; Sabo PJ; Vierstra J; Voit RA; Yuan GC; Porteus MH; Stamatoyannopoulos JA; Lettre G; Orkin SH
    Science; 2013 Oct; 342(6155):253-7. PubMed ID: 24115442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells.
    Amaya M; Desai M; Gnanapragasam MN; Wang SZ; Zu Zhu S; Williams DC; Ginder GD
    Blood; 2013 Apr; 121(17):3493-501. PubMed ID: 23444401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
    Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
    Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
    Xu J; Bauer DE; Kerenyi MA; Vo TD; Hou S; Hsu YJ; Yao H; Trowbridge JJ; Mandel G; Orkin SH
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6518-23. PubMed ID: 23576758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.
    Trakarnsanga K; Wilson MC; Lau W; Singleton BK; Parsons SF; Sakuntanaga P; Kurita R; Nakamura Y; Anstee DJ; Frayne J
    Haematologica; 2014 Nov; 99(11):1677-85. PubMed ID: 25107887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
    Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
    Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.
    Xu J; Sankaran VG; Ni M; Menne TF; Puram RV; Kim W; Orkin SH
    Genes Dev; 2010 Apr; 24(8):783-98. PubMed ID: 20395365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A.
    Lulli V; Romania P; Morsilli O; Cianciulli P; Gabbianelli M; Testa U; Giuliani A; Marziali G
    PLoS One; 2013; 8(4):e60436. PubMed ID: 23593217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.
    Jawaid K; Wahlberg K; Thein SL; Best S
    Blood Cells Mol Dis; 2010 Aug; 45(2):140-6. PubMed ID: 20542454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
    Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
    Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional silencing of fetal hemoglobin by BCL11A.
    Sankaran VG; Xu J; Orkin SH
    Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
    Canver MC; Smith EC; Sher F; Pinello L; Sanjana NE; Shalem O; Chen DD; Schupp PG; Vinjamur DS; Garcia SP; Luc S; Kurita R; Nakamura Y; Fujiwara Y; Maeda T; Yuan GC; Zhang F; Orkin SH; Bauer DE
    Nature; 2015 Nov; 527(7577):192-7. PubMed ID: 26375006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
    Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
    Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin genetics: recent contributions of GWAS and gene editing.
    Smith EC; Orkin SH
    Hum Mol Genet; 2016 Oct; 25(R2):R99-R105. PubMed ID: 27340226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.
    Huang P; Peslak SA; Lan X; Khandros E; Yano JA; Sharma M; Keller CA; Giardine B; Qin K; Abdulmalik O; Hardison RC; Shi J; Blobel GA
    Blood; 2020 Jun; 135(24):2121-2132. PubMed ID: 32299090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.
    Rajendiran V; Devaraju N; Haddad M; Ravi NS; Panigrahi L; Paul J; Gopalakrishnan C; Wyman S; Ariudainambi K; Mahalingam G; Periyasami Y; Prasad K; George A; Sukumaran D; Gopinathan S; Pai AA; Nakamura Y; Balasubramanian P; Ramalingam R; Thangavel S; Velayudhan SR; Corn JE; Mackay JP; Marepally S; Srivastava A; Crossley M; Mohankumar KM
    Mol Ther; 2024 Mar; 32(3):663-677. PubMed ID: 38273654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.
    Guda S; Brendel C; Renella R; Du P; Bauer DE; Canver MC; Grenier JK; Grimson AW; Kamran SC; Thornton J; de Boer H; Root DE; Milsom MD; Orkin SH; Gregory RI; Williams DA
    Mol Ther; 2015 Sep; 23(9):1465-74. PubMed ID: 26080908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
    Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
    Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediaries of branched chain amino acid metabolism induce fetal hemoglobin, and repress SOX6 and BCL11A, in definitive erythroid cells.
    Karkashon S; Raghupathy R; Bhatia H; Dutta A; Hess S; Higgs J; Tifft CJ; Little JA
    Blood Cells Mol Dis; 2015 Aug; 55(2):161-7. PubMed ID: 26142333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.